Enjoy unparalleled accuracy, speed, and efficiency with Genetoo’s photonic laser processing for prosthetic implants. Featured at the 2022 CLEO conference, this company is the future of biomedicine. Find out why below.
Having presented its innovative laser surface texturing strategy at the renowned 2022 CLEO Conference and Exhibition, the Gaithersburg, MD-based medical technology firm provides you with a laser-based solution to infection prevention in prosthetic limbs.
Genetoo’s appearance at the conference affirms its position as a leading proponent of innovative biotechnology for the medical sector. The company is changing the face of bacteria elimination on implant surfaces. Recent data published by the company reveals that Genetoo's photonics technology eradicates 99.998% of S. Aureus MRSA bacteria upon contact.
For a game-changing solution to post-implant infection, you need Genetoo Inc. More details at https://Genetoo.com
The company offers medical providers like you state-of-the-art laser texturing that inhibits bacteria attachments and biofilm growth, allowing the interaction of body tissue around the implant site. Genetoo provides a viable, environmentally-friendly alternative to standard antibiotic treatments for your implant patients.
The CLEO conference is a highly-respected and globally acclaimed showcase for leading research in fields such as biophotonics, manufacturing, and telecommunications. Held in San Jose, CA, this yearly event puts a spotlight on companies such as Genetoo Inc that are impacting the application of laser technology in the medical world.
Genetoo modifies surface energy via direct laser ablative surface patterning. This reduces bacterial adhesion and inhibits the formation and growth of biofouling. The company's proprietary technology creates surfaces with bactericidal properties. Studies suggest this process is unrivaled in terms of its effectiveness against bacterial growth on prosthetics.
You can use Genetoo’s laser surface texturing in a variety of medical contexts. These include orthopedic, dental, cardiac, and electronic implants as well as endoscopic devices. Genetoo's investment in research and development increases its productivity and reduces operational costs over the long term. Be a part of the new revolution in biomedicine.
About Genetoo
The company has been leading the way in biotechnical research innovation in the US since 2017. Genetoo's core technology has been licensed by the National Aeronautics and Space Administration. An active partnership with the NASA Space Technology Mission Directorate and its keynote presentation at the CLEO conference is indicative of Genetoo's position at the forefront of the biomedical laser processing space.
A spokesperson says, “Our goal is to reduce the number of infections associated with prosthetic implant surgeries, cutting all of the related pain and collateral costs.”
Genetoo continues to establish its reputation as a pioneer of laser surface texturing, arming the medical community and implant patients with safer, more precise, cost-effective bacteria elimination solutions.
Killing over 99% of bacteria. What once was science fiction is now becoming true, join the laser revolution, and get onboard with Genetoo. Find out more here: https://Genetoo.com
Now you can harness the advanced power of laser surface texturing and AI to deliver better patient outcomes and save lives. Make the right call with Genetoo.
